Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Cell & Gene Therapy Logo
Cell & Gene Therapy CB Rank
2264830
Heat Score
38
Cell & Gene Therapy is an online, open access, and peer-reviewed journal.
Founded
obfuscation
Private www.insights.bio/cell-and-gene-therapy-insights/
Overview

Cell & Gene Therapy
Heat Score
38

Growth Score
pts
in past quarter
Heat Score 38
-15 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
See more interactive data and historical milestones on desktop for the best experience

About Cell & Gene Therapy

CB Rank
2264830
Cell & Gene Therapy is an online, open access, and peer-reviewed journal.
Founded
obfuscation
Private www.insights.bio/cell-and-gene-therapy-insights/

Key People

  • Photo of Chris Mason
    Chris Mason: Senior Editor
    Past Role: University College London (UCL), Professor of Regenerative Medicine Bioprocessing

Details

Operating Status Active
Company Type For Profit
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Cell & Gene Therapy Insights
An online, open access, peer-reviewed journal focused on translational research in cell and gene therapy.
Webinars and Roundtables
Educational and discussion events on scientific, regulatory, and technical topics in cell and gene therapy.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Employee Profiles 1

Employee Profiles

News

News and Press

News•Oct 21, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 10, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Feb 27, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Nov 13, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

IT Spend

$412.3KThis year, Cell & Gene Therapy is projected to spend $412.3K on IT, according to Aberdeen.
Sub-Organizations
Frequently Asked Questions

Who are Cell & Gene Therapy's competitors? Alternatives and possible competitors to Cell & Gene Therapy may include BioAlliance Strategies, All4Cure, and  Manchester Cancer Research Centre.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(8fe006b 1)
|